Olaax Corp. Issues a Nationwide Voluntary Recall of All Lots of Maxiloss Weight Advanced Softgels Dietary Supplement

You are subscribed to Recalls, Market Withdrawals and Safety Alerts for U.S. Food & Drug Administration (FDA).

This information has recently been updated and is now available.

 

Olaax Corp. Issues a Nationwide Voluntary Recall of All Lots of Maxiloss Weight Advanced Softgels Dietary Supplement

02/25/2013 10:17 AM EST

Olaax Corp announced today that it is conducting a voluntary nationwide recall of the company's dietary supplement sold under the brand name MAXILOSS WEIGHT ADVANCED softgels to the user level because they contain undeclared Sibutramine. Olaax Corp. is conducting a voluntary recall after being notified by the US FDA that testing found the MAXILOSS WEIGHT ADVANCED product, to contain Sibutramine.

. For detailed information pertaining to this Recalls, Market Withdrawals and Safety Alerts message, please click the link at the beginning of this bulletin.

---

Manage your FDA Subscriptions:

• Update your preferences or unsubscribe
• Questions about this service? support@govdelivery.com
• Other inquiries? webmail@oc.fda.gov

---

This email was sent to filter@clubhouseb.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420